OLD Category: immuno-oncology
May 7, 2018 / Cell
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
April 30, 2018 / Clin. Can. Res,
Novel effector phenotype of Tim-3+ regulatory T cells leads to enhanced suppressive function in head and neck cancer patients
April 30, 2018 / J. Immunother, Cancer
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
April 1, 2018 / J. Interferon Cytokine Res.
Development of a Validated Interferon Score Using NanoString Technology
March 28, 2018 / Front. Mol. Neurosci.
The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
March 22, 2018 / Front. Oncol.
Association Between Programmed Death-Ligand 1 Expression and the Vascular Endothelial Growth Factor Pathway in Angiosarcoma
March 5, 2018 / JCI
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
February 22, 2018 / Nat. Commun.